A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

about

Multi-Stakeholder Decision Aid for Improved Prioritization of the Public Health Impact of Climate Sensitive Infectious Diseases

P2860

Q30384863-6C9C0AE5-60E7-4944-B4E0-A97253B18343

P2860

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

Item

http://www.wikidata.org/entity/Q42977175

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@en

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@nl

type

Item

label

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@en

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@nl

prefLabel

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@en

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@nl

P1476

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

@en

P2093

Monica A McArthur

http://www.w3.org/2001/XMLSchema#string

Robert Edelman

http://www.w3.org/2001/XMLSchema#string

P2860

The global distribution and burden of dengue

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Dengue

Dengue human infection model: introduction.

Dengue.

Dengue vaccines: recent developments, ongoing challenges and current candidates.

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

Efficacy of a tetravalent dengue vaccine in children in Latin America.

Health economics of dengue: a systematic literature review and expert panel's assessment.

P304

681-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/INFDIS/JIV086

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

212

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274086687

http://www.w3.org/2001/XMLSchema#string

P698

25801651

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

about

P2860

P2860

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921